Influence of Bodily Practices on the Quality of Life of Women With Endometriosis (PCKendo)

Influence of Bodily Practices on the Quality of Life of Women

This research focuses on understanding how physical activity can improve the quality of life for women with endometriosis by enhancing their self-perception, particularly regarding their physical abilities and appearance. The study is based on the idea that improving internal perceptions can lead to better overall well-being for these women. Previous studies, suggest that physical self-perception plays a crucial role in shaping an individual's quality of life. There is also evidence supporting a reciprocal relationship between physical self-concept and participation in physical activity

In this context, the research aims to explore how physical activity could positively influence the self-concept of women suffering from endometriosis, which in turn could enhance their quality of life. By focusing on improving both physical abilities and body image through regular exercise, this study seeks to offer insights into potential therapeutic approaches for managing the physical and psychological impacts of endometriosis.

Study Overview

• Status: Completed
• Conditions: Endometriosis
• Intervention / Treatment: Other: physical activity; Other: analgesic physical therapy; Other: analgesic physical therapy AND physical activity

• Study Type: Interventional
• Enrollment (Actual): 52
• Phase: Not Applicable

Contacts and Locations

Study Locations

• France
  • Chevry-Cossigny, France
    • Physical Therapy Studio
  • Paris, France, 75014
    • Hopital Saint Joseph

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Menstruating women aged 18 to 55;
• proven diagnosis of endometriosis (pelvic ultrasound or MRI)
• Having endometriosis-related pain of a level higher than 3 on the VAS scale and/or chronic incapacitating symptoms related to endometriosis;
• Patient without treatment or with stable endometriosis treatment (pill and/or ATG) who has not undergone treatment during the last 6 months;
• Patient affiliated to a health insurance scheme;
• French-speaking patient;
• Patient having given free, informed and express oral consent.

Exclusion Criteria:

• Any patient whose endometriosis treatment has been modified for less than 6 months;
• Having endometriosis-related pain greater than or equal to 8 on the VAS scale;
• Cardiovascular risks related to physical training;
• Inability to perform proposed exercises;
• Patient under guardianship;
• Patient deprived of liberty;

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: physical activity	Other: physical activity; 40 min circuit training session
Active Comparator: analgesic physical therapy	Other: analgesic physical therapy; physical therapy with massage and Transcutaneous Electrical Nerve Stimulation in a 40min session
Experimental: analgesic physical therapy AND physical activity	Other: analgesic physical therapy AND physical activity; 25 min circuit training session and 15 min physical therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Evaluation of quality of life	Endometriosis Health Profile-30 (EHP-30) questionnaire	6months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Global Self Esteem evaluation	Rosenberg questionnaire	at enrollement, 3 and 6 months after enrollement
evaluation of physical self esteem	Physical Self Description questionnaire - short form (PSDQ-S)	at enrollement, at 3 and 6 months after enrollement
Pain Evaluation	Numerical pain rating scale	at enrollement, 3 and 6 months after enrollement

Collaborators and Investigators

• Sponsor: Fondation Hôpital Saint-Joseph
• Investigators: Principal Investigator: Frederique PERROTTE, Fondation Hôpital Saint-Joseph

Study record dates

Study Major Dates

• Study Start (Actual): March 21, 2024
• Primary Completion (Actual): December 31, 2025
• Study Completion (Actual): July 1, 2026

Study Registration Dates

• First Submitted: October 24, 2024
• First Submitted That Met QC Criteria: October 24, 2024
• First Posted (Actual): October 26, 2024

Study Record Updates

• Last Update Posted (Actual): September 8, 2026
• Last Update Submitted That Met QC Criteria: September 2, 2026
• Last Verified: September 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Urogenital Diseases; Genital Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Genital Diseases, Female; Endometriosis; Motor Activity; Movement; Musculoskeletal Physiological Phenomena; Musculoskeletal and Neural Physiological Phenomena; Exercise
• Other Study ID Numbers: 665-PCKendo

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No